Opus Point Partners Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$303K Hold
6,204
0.55% 38
2019
Q2
$323K Hold
6,204
0.48% 49
2019
Q1
$308K Sell
6,204
-844
-12% -$38K 0.42% 59
2018
Q4
$255K Sell
7,048
-1,920
-21% -$80.2K 0.56% 31
2018
Q3
$458K Buy
8,968
+1,340
+18% +$59.4K 1.09% 27
2018
Q2
$282K Sell
7,628
-408
-5% -$15.6K 0.61% 39
2018
Q1
$303K Buy
8,036
+88
+1% +$3.11K 0.59% 35
2017
Q4
$257K Sell
7,948
-9,124
-53% -$290K 0.22% 52
2017
Q3
$516K Buy
17,072
+8,624
+102% +$256K 0.46% 49
2017
Q2
$248K Sell
8,448
-6,712
-44% -$183K 0.23% 57
2017
Q1
$385K Buy
15,160
+5,292
+54% +$137K 0.29% 56
2016
Q4
$254K Buy
+9,868
New +$259K 0.2% 47
2015
Q4
Sell
-188,000
Closed -$4.35M 62
2015
Q3
$4.35M Buy
188,000
+52,000
+38% +$1.3M 2.4% 15
2015
Q2
$3.35M Buy
136,000
+12,332
+10% +$308K 2.65% 21
2015
Q1
$3.1M Buy
123,668
+12,068
+11% +$287K 2.6% 22
2014
Q4
$2.58M Buy
+111,600
New +$2.55M 2.55% 21

Other funds holding TECH

Opus Point Partners Management's TECH Position: Q3 2019 in Review

Opus Point Partners Management held its Bio-Techne (TECH) position steady in Q3 2019 at 6,204 shares worth $303K. The position accounts for 0.55% of the portfolio, ranked #38.

Opus Point Partners Management first reported a position in TECH in Q4 2014 and has held it in 16 quarters since. The position peaked at $4.35M in Q3 2015. 341 funds tracked by Wall St. Rank hold TECH as of Q3 2019.

  • Opus Point Partners Management held 6,204 shares of Bio-Techne worth $303K as of Q3 2019.
  • Opus Point Partners Management left its Bio-Techne share count unchanged in Q3 2019.
  • Bio-Techne made up 0.55% of Opus Point Partners Management's portfolio in Q3 2019, its #38 holding.
  • Opus Point Partners Management first reported a position in Bio-Techne in Q4 2014 and has held it in 16 quarters since.
  • Opus Point Partners Management's Bio-Techne position peaked at $4.35M in Q3 2015.
  • 341 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2019.

Based on Opus Point Partners Management's 13F filing for Q3 2019, filed 14 Nov 2019.